Literature DB >> 1320245

Demonstration of an activated platelet-derived growth factor autocrine pathway and its role in human tumor cell proliferation in vitro.

T P Fleming1, T Matsui, M A Heidaran, C J Molloy, J Artrip, S A Aaronson.   

Abstract

In tumor cells expressing platelet-derived growth factor (PDGF) ligand(s) and receptor(s), immunoblot analysis established tyrosine phosphorylation of PDGF receptors (PDGFRs) in the absence of any exogenous ligand, implying chronic receptor activation. Exposure to suramin resulted in diminished receptor autophosphorylation and/or up-regulation of receptor protein. In a subset of such tumor lines, there was a marked reduction in DNA synthesis in response to suramin or PDGF-neutralizing antiserum. These findings demonstrate that autocrine PDGF stimulation contributes to proliferation of some human tumors and that agents which interfere with ligand-receptor interactions at the cell surface can significantly interfere in this process.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320245

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.

Authors:  H Weber; D S Taylor; C J Molloy
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

2.  Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.

Authors:  A L Gashler; D T Bonthron; S L Madden; F J Rauscher; T Collins; V P Sukhatme
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

3.  Identification and characterization of an essential, activating regulatory element of the human SIS/PDGFB promoter in human megakaryocytes.

Authors:  H M Jin; M L Brady; W E Fahl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

4.  Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors.

Authors:  T M Weiner; E T Liu; R J Craven; W G Cance
Journal:  Ann Surg Oncol       Date:  1994-01       Impact factor: 5.344

5.  A dominant-negative mutant of the platelet-derived growth factor A-chain increases survival of hamsters implanted intracerebrally with the highly invasive CxT24-neo3 glioblastoma cell.

Authors:  D M Kaetzel; J D Reid; N Pedigo; S G Zimmer; E R Boghaert
Journal:  J Neurooncol       Date:  1998-08       Impact factor: 4.130

6.  Human neuroblastoma cells express alpha and beta platelet-derived growth factor receptors coupling with neurotrophic and chemotactic signaling.

Authors:  T Matsui; K Sano; T Tsukamoto; M Ito; T Takaishi; H Nakata; H Nakamura; K Chihara
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

7.  Neural development and the ontogeny of central nervous system tumors.

Authors:  Scott L Pomeroy
Journal:  Neuron Glia Biol       Date:  2004-05

8.  Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells.

Authors:  S M Shamah; C D Stiles; A Guha
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

9.  Positive immunostaining for platelet derived growth factor (PDGF) is an adverse prognostic factor in patients with advanced breast cancer.

Authors:  L Seymour; W R Bezwoda
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Innovative Therapies against Human Glioblastoma Multiforme.

Authors:  Annamaria Cimini; Rodolfo Ippoliti
Journal:  ISRN Oncol       Date:  2011-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.